An Extension Study of An Investigational Drug in Patients With Hypercholesterolemia (0653A-038)(COMPLETED)
NCT00092664
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1104
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypercholesterolemia
Interventions
DRUG:
MK0653A, ezetimibe (+) simvastatin / Duration of Treatment: 14 weeks
Sponsor
Organon and Co